MODULE 12

Module 12: Gastrointestinal Tract Medications

Structure & Function Review
  • Accessory Organs of the Digestive System:

    • Mouth

    • Salivary Glands

    • Liver

    • Gallbladder

    • Appendix

    • Esophagus

    • Stomach

    • Pancreas

    • Large Intestine

    • Small Intestine

    • Rectum

    • Anus

Common Gastrointestinal Disorders
  • Peptic Ulcer Disease

  • GERD (Gastroesophageal Reflux Disease)

  • Gastrointestinal Disorders

  • Nausea & Vomiting

  • Diarrhea

  • Constipation

  • IBD (Irritable Bowel Disease)

Peptic Ulcer Disease
  • Definition:

    • Erosion of the mucosal layer of the stomach or duodenum

  • Causes:

    • Helicobacter pylori (bacteria)

    • NSAID use

GERD (Gastroesophageal Reflux Disease)
  • Definition:

    • Weakening or relaxation of the esophageal sphincter

  • Signs & Symptoms:

    • Heartburn

    • Dysphagia (difficulty swallowing)

    • Dyspepsia (indigestion)

    • Chest pain

    • Nausea

    • Belching

Pharmacotherapy for Peptic Ulcers & GERD
  • Medications Used:

    • H2-receptor antagonists (Histamine2-blockers)

    • Proton Pump Inhibitors (PPIs)

    • OTC Antacids

    • Antibiotics (discussed in the next module)

H2-Receptor Antagonists
  • Mechanism of Action:

    • Inhibit histamine at H2-receptor sites in parietal cells, decreasing gastric acid secretions

  • Indications:

    • Treat symptoms of Peptic Ulcer Disease and GERD

  • Long-term Use Implication:

    • May lead to Vitamin B12 deficiency

  • Example:

    • Ranitidine (Zantac)

Proton Pump Inhibitors (PPIs)
  • Mechanism of Action:

    • Reduce acid secretion in the stomach

  • Comparative Efficacy:

    • Greater efficacy than H2 receptor antagonists

  • Durability:

    • Longer duration of action

  • Administration Considerations:

    • Take 30 minutes before meals (i.e., breakfast)

  • Side/Adverse Effects:

    • Diarrhea, headache, dizziness

    • Potential for gastric cancer with long-term use

Nursing Considerations for H2 Blockers and PPIs
  • Medication Interactions:

    • May affect absorption of other medications; identify which medications are impacted

  • Timing of Administration:

    • Importance of taking medications 30 minutes prior to eating

  • Non-pharmacological Ways to Reduce GERD:

Antacids
  • Classification:

    • Over the counter (OTC) medications

  • Mechanism of Action:

    • Alkaline substances that neutralize gastric acid

  • Considerations:

    • Affect absorption of many drugs

Nursing Considerations for Antacids
  • Adverse Effects:

    • Constipation (calcium and aluminum-based antacids)

    • Diarrhea (magnesium-based antacids)

    • Electrolyte imbalances

  • Administration Guidance:

    • Take at least 2 hours before or 2 hours after other oral medications

    • Patients with renal failure should avoid magnesium-based antacids

Nausea & Vomiting
  • Causes of Vomiting:

    • Various causes — further details provided in specific treatment discussions

  • Non-pharmacological Methods to Control Vomiting:

  • Inducing Vomiting:

    • Evaluation of when to induce vomiting and associated safety considerations

  • Serious Consequences:

    • Dehydration, electrolyte imbalances

Mechanism of Vomiting
  • Controlled by the vomiting center located in the medulla

    • Receives signals from the digestive tract, inner ear, and cerebral cortex

Anti-Emetics
  • Definition:

    • Emesis refers to vomit

  • Therapeutic Use:

    • Decrease nausea and reduce vomiting

  • Mechanism of Action:

    • Dependent on the chemical classification of the antiemetic

  • Types of Anti-emetics:

    • Anticholinergics and Antihistamines

    • Dopamine Antagonists

    • Serotonin (5-HT3) Receptor Antagonists

Anticholinergic and Antihistamines
  • Use Cases:

    • Effective for treating simple nausea; some versions available OTC

  • Mechanism of Action:

    • Work by inhibiting vestibular stimulation in the middle ear

  • Applications:

    • Effective for nausea, vomiting, and motion sickness

  • Examples:

    • Dimenhydrinate (Gravol)

    • Meclizine (Bonamine)

Nursing Considerations for Antihistamines & Anticholinergics
  • Side Effects to Monitor:

  • Patient Teaching Points:

  • Case Scenarios:

    • Inquiry regarding effects of administering specific medications under certain conditions like constipation

Dopamine Antagonists
  • Mechanism of Action:

    • Block dopamine II receptor sites in the brain responsible for inducing vomiting

  • Examples:

    • Metoclopramide (Maxeran)

    • Increases peristalsis and is best given IV for severe nausea and vomiting

Serotonin Receptor Blockers
  • Example:

    • Ondansetron

  • Usage Limitation:

    • Typically used for nausea and vomiting associated with antineoplastic therapy; prescription only and expensive

Lower GI Tract Agents
  • Categories of Agents:

    • Anti-inflammatory

    • Laxatives

    • Antidiarrheals

    • Medications for IBD

Inflammatory Bowel Disease (IBD)
  • Types:

    • Crohn’s Disease

    • Lesions in the digestive tract

  • Etiology:

    • Unknown, suspected autoimmune

  • Symptoms:

    • Abdominal cramping and frequent bowel movements

IBD Medications
  • Categories of Medications:

    • Aminosalicylates

    • Antibiotics

    • Corticosteroids

    • Immunomodulators

    • Biologic therapies

Constipation
  • Factors Contributing to Constipation:

    • Various biological, psychological, and social factors

  • Symptoms Associated with Constipation:

  • Non-pharmacological Methods to Alleviate Constipation:

Pharmacotherapy of Constipation
  • Laxatives Classification:

    • Prophylactic

    • Treatment drugs that promote evacuation of the large bowel

    • Types:

    • Osmotic laxatives

    • Bulk-forming laxatives

    • Emollients (stool softeners)

    • Stimulant laxatives

Osmotic Laxatives (Hyperosmotic Agents)
  • Mechanism of Action:

    • Not absorbed in the intestine; pull water into feces from surrounding tissues, softening the stools and facilitating peristalsis

  • Risk Considerations:

    • Normal renal function required; can cause electrolyte imbalances

  • Example:

    • Lactulose, which also reduces ammonia levels in the bloodstream

Bulk-Forming Laxatives
  • Mechanism of Action:

    • Absorb liquid in the intestines, swell to form soft bulky stool to stimulate bowel movements

  • Example:

    • Psyllium (Metamucil)

Emollients (Stool Softeners)
  • Mechanism of Action:

    • Encourage bowel movements by helping liquids mix in the stool, acting as a lubricant to prevent dry hard stool

  • Example:

    • Docusate sodium (Colace)

Stimulant Laxatives
  • Mechanism of Action:

    • Trigger contractions in intestinal muscles (promote peristalsis) by irritating sensory nerve endings; cramping is a common side effect

  • Additional Actions:

    • Increase water in the stool via absorption inhibition or secretion stimulation

  • Example:

    • Bisacodyl (Dulcolax)

Laxatives: Adverse Effects
  • Potential Adverse Effects:

    • Diarrhea

    • Electrolyte imbalances

    • Dehydration

    • Abdominal pain

    • Decreased absorption of other medications

Diarrhea
  • Causes of Diarrhea:

    • Various etiologies — to be discussed further in the treatment section

  • Life-Threatening Consideration:

    • Diarrhea can be life-threatening in certain populations, such as the elderly and infants

  • Non-pharmacological Treatment Methods:

Antidiarrheals
  • Mechanism of Action:

    • Act systemically or locally to ameliorate diarrhea; classifications include opioid-related drugs and absorbents

Antidiarrheal Medications - Opiates
  • Mechanism of Action:

    • Systematically depress CNS, decreasing peristalsis; allows for more time for water and salts to be reabsorbed

  • Example:

    • Loperamide (Imodium)

Antidiarrheal Medications - Absorbents
  • Mechanism of Action:

    • Work by coating the wall of the GI tract and absorbing/inhibiting activity of bacteria or toxins

  • Example:

    • Bismuth subsalicylate (Pepto-Bismol)

Case Study: Mrs. Sadie
  • Patient Information:

    • An 85-year-old female presenting with abdominal pain, vomiting, and no bowel movement for 4 days despite taking Metamucil for 2 days.

Assessment – Mrs. Sadie
  • Physical Findings:

    • Abdomen distended, painful on palpation, dry mucous membranes, no flatus

  • Vital Signs:

    • T 36.7, HR 110, BP 99/57, RR 18, O2 sat 90% on RA

  • Medications:

    • Tylenol #3 (for arthritis) and Lipitor for high cholesterol

  • Medical History:

    • Arthritis, high cholesterol, history of appendectomy, and gallbladder removal

Considerations for Assessment
  • Risk Factors for Constipation:

  • Risk Factors for Bowel Obstruction:

  • Evaluation of Vital Signs:

Patient Responses During Treatment
  • Patient Inquiry:

    • Patient requested a stronger laxative to address her issues at home; consider the best response and care approach.

Follow-Up Case Assessment
  • Outcome:

    • After CT scan, diagnosed with constipation, sent home with a fleet enema

  • Medication Classification Inquiry:

    • Identify the type of laxative that a fleet enema represents.